Company Profile of Shenzhen Kangtai Biological Products Co.,Ltd.

BioKangtai established in 1992, focusing on the R&D, production and distribution of human preventive vaccines, listed on the Shenzhen Stock Exchange on February 7, 2017 (stock code:300601), also is the first listed vaccine enterprise in South China. As one of the largest private vaccines manufacturers in China, BioKangtai owns 5 vaccine centers across 2 major cities: 3 centers in Shenzhen and 2 centers in Beijing, offering sufficient production and innovation capacity, the marketing and distribution network covers 31 provinces (autonomous regions and municipalities) in China. Since establishment over 30 years, BioKangtai has developed into a high-tech enterprise with great R&D varieties, rich product lines and significant technical advantages. We have more than 50 patents totally and more than 30 in-house developed products, basically covering the world's key vaccine varieties. Up to 2022, the number of marketed vaccine and R&D varieties of BioKangtai ranked first in China's vaccine industry, including more than 10 vaccine products under manufacturing : 10μg、20μg and 60μg Recombinant HepB Vaccine; DTaP-Hib combined vaccine; DTaP combined vaccine, absorbed; 13-valent pneumococcal polysaccharide conjugate vaccine（TT/DT）, 23-valent pneumococcal polysaccharide vaccine; Hib conjugate vaccine; Hib conjugate vaccine, freeze-dried; Measles and rubella combined vaccine, live; and Covid-19 inactivated vaccine that has been authorized for emergency use in China since May, 2021. Meanwhile, the HDCV rabies vaccine, Sabin-inactivated poliomyelitis vaccine, Varicella vaccine and other types of vaccines are under developing. Aiming at creating the best vaccines to benefit human health, BioKangtai always put the product quality first and had built a strict GMP management system. With an effective quality assurance system that ensures strict control of all aspects of production, consistently produce vaccines that meet highest quality specifications, our vaccines also have been recognized and registered in some other countries, and the list keeps expanding.